Who is sponsoring NCT04309123?

NCT04309123 is sponsored by Synapse Biomedical.

What drugs are being tested in NCT04309123?

Interventions in NCT04309123: TransAeris System.

What condition does NCT04309123 study?

NCT04309123 studies Ventilator-Induced Diaphragm Dysfunction.

Is NCT04309123 still recruiting?

NCT04309123 is currently completed. Last updated 8 April 2021.

Last reviewed 2021-04-08 · How we verify

NCT04309123: TRANSITION

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Pilot Study of TransAeris® System in Surgical Patients at Risk of Prolonged Mechanical Ventilation

Completed NA Last updated 8 April 2021

What this trial tests

NA trial testing TransAeris System in Ventilator-Induced Diaphragm Dysfunction in 40 participants. Completed in 1 April 2021.

Timeline

30 March 2020

Primary endpoint
31 March 2021

1 April 2021

Quick facts

Lead sponsor	Synapse Biomedical
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	40
Start date	30 March 2020
Primary completion	31 March 2021
Estimated completion	1 April 2021
Sites	1 location across United States

Drugs / interventions tested

TransAeris System

Conditions studied

Ventilator-Induced Diaphragm Dysfunction — all drugs for Ventilator-Induced Diaphragm Dysfunction →

Sponsor

Synapse Biomedical

Who can join

22 and older, any sex, with Ventilator-Induced Diaphragm Dysfunction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will be conducted as a pilot trial of the TransAeris system for the prevention and treatment of ventilator-induced diaphragm dysfunction (VIDD) in patients identified prior to surgery to be at greater risk of prolonged mechanical ventilation (PMV).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of TransAeris System

Trials testing the same drug.

NCT05404477 — Study of TransAeris® System for Enhanced Recovery After Surgery in France · NA · completed

Other Synapse Biomedical trials

Trials by the same sponsor.

NCT05404477 — Study of TransAeris® System for Enhanced Recovery After Surgery in France · NA · completed
NCT03034317 — NeuRx Diaphram Pacing System (DPS) Use in Amyotrophic Lateral Sclerosis (ALS) · NA · withdrawn

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04309123 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Synapse Biomedical
Last refreshed: 8 April 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04309123.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing